We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+32.65%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.1B
AUM Growth
-$1.29B
Cap. Flow
-$1.61B
Cap. Flow %
-76.67%
Top 10 Hldgs %
43.41%
Holding
94
New
23
Increased
6
Reduced
30
Closed
33

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$63.4M
2
ELV icon
Elevance Health
ELV
+$54.6M
3
CNC icon
Centene
CNC
+$44.4M
4
PFE icon
Pfizer
PFE
+$34.7M
5
ICUI icon
ICU Medical
ICUI
+$28.5M

Top Sells

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$121M
2
PEN icon
Penumbra
PEN
+$97.1M
3
ZBH icon
Zimmer Biomet
ZBH
+$77.5M
4
NXPI icon
NXP Semiconductors
NXPI
+$75.2M
5
MCHP icon
Microchip Technology
MCHP
+$72.3M

Sector Composition

Rank Sector Weight
1 Healthcare 69.54%
2 Technology 2.78%
3 Consumer Discretionary 0.53%
4 Financials 0.1%
5 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
V icon
76
Visa
V
$684B
– –
-134,188
Closed -$23.1M
VYGR icon
77
Voyager Therapeutics
VYGR
$183M
– –
-1,231,954
Closed -$21.2M
WDC icon
78
Western Digital
WDC
$188B
– –
-1,053,001
Closed -$47.5M
XBI icon
79
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.95B
– –
-1,143,600
Closed -$87.2M
TECX
80
Tectonic Therapeutic
TECX
$529M
– –
-65,331
Closed -$11.1M
AMK
81
DELISTED
AssetMark Financial Holdings, Inc.
AMK
– –
-29,259
Closed -$762K
MRTX
82
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-431,123
Closed -$33.6M
TWTR
83
DELISTED
Twitter, Inc.
TWTR
– –
-477,780
Closed -$19.7M
ALNA
84
DELISTED
Allena Pharmaceuticals
ALNA
– –
-486,978
Closed -$1.92M
EIDX
85
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
– –
-126,181
Closed -$4.54M
MYOK
86
DELISTED
MyoKardia, Inc. Common Stock
MYOK
– –
-1,227,371
Closed -$64M
LVGO
87
DELISTED
Livongo Health, Inc. Common Stock
LVGO
– –
-106,380
Closed -$1.85M
DLPH
88
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
– –
-429,452
Closed -$5.75M
PRNB
89
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
– –
-559,553
Closed -$15.8M
WCG
90
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-263,626
Closed -$68.3M
1 2 3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return

PFM Health Sciences's Q4 2019 Portfolio in Review

As of Q4 2019, PFM Health Sciences held 94 positions worth $2.1B, down 38% from $3.39B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

PFM Health Sciences withdrew a net $1.61B in Q4 2019, closing 33 positions and reducing 30 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $68.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PFM Health Sciences opened a new position in Biogen worth $67.8M.

  • PFM Health Sciences's largest Q4 2019 buy was Biogen: 228,328 shares worth $67.8M.
  • PFM Health Sciences added most to NEVRO CORP. in Q4 2019, an estimated $17.9M increase.
  • PFM Health Sciences's biggest Q4 2019 reduction was BioMarin Pharmaceuticals, cutting an estimated $121M.
  • PFM Health Sciences fully exited Wellcare Health Plans, Inc. in Q4 2019, selling an estimated $68.3M.
  • PFM Health Sciences's ten largest holdings make up 43% of its $2.1B portfolio in Q4 2019.
  • PFM Health Sciences opened 23 new positions and closed 33 in Q4 2019.
  • PFM Health Sciences's portfolio value fell 38% quarter-over-quarter to $2.1B.

Based on PFM Health Sciences's 13F filing for Q4 2019, filed 14 Feb 2020.